Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions

Advanced Drug Delivery Reviews

Volumn 32, Issue 1-2, 1998, Pages 119-138

  Papisov, Mikhail I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drug carrier; Drug delivery; Drug targeting; Liposome; Macromolecule; Modeling; Pharmacokinetics; Polymer; Steric protection

Indexed keywords

CELLS; DRUG INTERACTIONS; MACROMOLECULES; MASS TRANSFER; MATHEMATICAL MODELS; MOLECULAR DYNAMICS; MOLECULAR STRUCTURE; PHARMACOKINETICS; PROTEINS; SURFACE TREATMENT;

LIPOSOMES;

CONTROLLED DRUG DELIVERY;

LIPOSOME; POLYMER;

DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG TARGETING; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; REVIEW; THEORY;

EID: 0032496715     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00135-X     Document Type: Review

References (108)

1. G. Gregoriadis (Ed.), Liposome Technology, 2nd ed., CRC Press, Boca Raton, FL, 1993.
2. Woodle M.C., Lasic D.D. Sterically stabilized liposomes. Biochim. Biophys. Acta. 1113:1992;171-199.
3. Woodle M.C. Sterically stabilized liposome therapeutics. Adv. Drug Deliv. Rev. 16:1995;249-266.
4. P.R. Chaturvedi, Pharmacokinetics of microparticular systems, in: S. Cohen, H. Bernstein (Eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996.
5. Allen T.M., Hansen C.B., de Menzes D.E.L. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16:1995;267.
6. Papisov M.I. Modeling in vivo transfer of long-circulating polymers (two classes of long circulating polymers and factors affecting their transfer in vivo). Adv. Drug Deliv. Rev. 16:1995;127-137.
7. Papisov M.I., Savelyev V.Y., Sergienko V.B., Torchilin V.P. Magnetic drug targeting (I) In vivo kinetics of radiolabeled magnetic drug carriers. Int. J. Pharm. 40:1987;201-206.
8. Schaffer B.S., Linker C., Papisov M.I., Tsai E., Nossiff N., Shibata T., Bogdanov A.A. Jr., Brady T.J., Weissleder R. MION-ASF: Biokinetics of an MR receptor agent. J. Magn. Res. Imag. 11:1993;411-417.
9. Papisov M.I., Torchilin V.P. Magnetic drug targeting (II) Targeted drug transport by magnetic microparticles: Factors influencing therapeutic effect. Int. J. Pharm. 40:1987;207-214.
10. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., Papahadjopoulos D. Versatility in lipid composition showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta. 1105:1992;193-200.
11. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., Jain R.K. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res. 55(17):1995;3752-3756.
12. V. Neufeltd (Ed.), Webster New World Dictionary of American English, third college edition, Webster New World, New York, 1988, p. 1314.
13. Jeon S.L., Lee J.H., Andrade J.D., DeGennes P.G. Protein-surface interactions in the presence of polyethylene oxide. J. Colloid Interface Sci. 142:1991;149-166.
14. Allen T.M., Austin G.A., Chonn A., Lin L., Lee K.C. Uptake of liposomes by cultured mouse bone marrow macrophages: Influence of liposome composition and size. Biochim. Biophys. Acta. 1061:1991;56-64.
15. Bradfield J.W.B. A new look at reticuloendothelial blockade. Br. J. Exp. Pathol. 61:1980;617-623.
16. Moghimi S.M., Patel H.M. Differencial properties of organ specific serum opsonins for liver and spleen macrophages. Biochim. Biophys. Acta. 984:1989;379-384.
17. Oja D.O., Semple S.C., Chonn A., Cullis P.R. Influence of dose on liposome clearance: Critical role of blood proteins. Biochim. Biophys. Acta. 1281:1996;31-37.
18. Moghimi S.M., Porter C.J.H., Muir I.S., Illum L., Davis S.S. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: Influence of particle size and hydrophylic coating. Biochem. Biophys. Res. Commun. 177:1991;861-866.
19. Atkinson J.P., Frank M.M. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J. Clin. Invest. 54:1974;339-348.
20. Walton K.W., Almond T.J., Robinson M., Scott D.L. An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes. Br. J. Exp. Pathol. 65:1984;191-200.
21. Benecky M.J., Kolvenbach C.G., Wine R.W., DiOrio J.P., Mosesson M.W. Human plasma fibronectin structure probed by steady-state fluorescence polarization: Evidence for a rigid oblate structure. Biochemistry. 29:1990;3082-3091.
22. Khan M.Y., Medow M.S., Newman S.A. Unfolding transitions of fibronectin and its domains. Biochem. J. 270:1990;33-38.
23. Kinoshita T. Biology of complement: The overture. Immunol. Today. 12:1991;291-301.
24. Law S.K., Lichtenberg N.A., Levine R.P. Covalent binding and hemolytic activity of complement proteins. Proc. Natl. Acad. Sci. USA. 77:1980;7194-7198.
25. Law S.K., Minich T.M., Levine R.P. Covalent binding efficacy of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups. Biochemistry. 23:1984;3267-3272.
26. Sim R.B., Reid K.B.M. C1: Molecular interactions with activating systems. Immunol. Today. 12:1991;307-311.
27. Young N.M., Leon M.A. The carbohydrate specificity of conglutinin and its homology to proteins in the hepatic lectin family. Biochem. Biophys. Res. Commun. 143:1987;645-651.
28. Ezekowitz R.A.B., Day L.E., Herman G.A. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J. Exp. Med. 167:1988;1034-1047.
29. Wright S.D., Tobias P.S., Ulevitch R.J., Ramos R.A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1989;1231-1241.
30. Tobias P.S., Soldau K., Kline L., Lee J.D., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:1993;3011-3021.
31. Savill J., Dransfield I., Hogg N., Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature. 343:1990;170-173.
32. Ehlenberger A.G., Nussenzweig V. The role of membrane receptors for C3b and C3d in phagocytosis. J. Exp. Med. 145:1977;357-371.
33. Ross G.D., Cain J.A., Lachmann P.J. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymozan and rabbit erythrocytes as well as a receptor for iC3b. J. Immunol. 134:1985;3307-3315.
34. Brown D.L., Lachmann P.J., Dacie J.V. The in vivo behavior of complement-coated red cells: Studies in C6-deficient, C3-depleted and normal rabbits. Clin. Exp. Immunol. 7:1970;401-422.
35. Atkinson J.P., Frank M.M. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J. Clin. Invest. 54:1974;339-348.
36. Brown D.L., Lachmann P.J., Dacie J.V. The in vivo behaviour of complement-coated red cells: Studies in C6-deficient, C3-depleted and normal rabbits. Clin. Exp. Immunol. 7:1970;401-422.
37. Senior J., Waters J.A., Gregoriadis G. Antibody-coated liposomes. The role of non-specific antibody adsorption. FEBS Lett. 196:1986;54-58.
38. Vazquez-Mellado J., Llorente L., Richaud-Patin Y., Alarcon-Segovia D. Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J. Autoimmun. 7:1994;335-348.
39. Benecky M.J., Kolvenbach C.G., Wine R.W., DiOrio J.P., Mosesson M.W. Human plsama fibronectin structure probed by steady-state fluorescence polarization: Evidence for a rigid oblate structure. Biochemistry. 29:1990;3082-3091.
40. Khan M.Y., Medow M.S., Newman S.A. Unfolding transitions of fibronectin and its domains. Biochem. J. 270:1990;33-38.
41. Wolff C., Lai C.S. Fluorescence energy transfer detects changes in fibronectin structure upon surface binding. Arch. Biochem. Biophys. 268:1989;536-545.
42. Walton K.W., Almond T.J., Robinson M., Scott D.L. An experimental model for the study of the opsonic activity of fibronectin in the clearance of intravascular complexes. Br. J. Exp. Pathol. 65:1984;191-200.
43. Hsu M.J., Juliano R.L. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim. Biophys. Acta. 720:1982;411-419.
44. Kinoshita T. Biology of complement: The overture. Immunol. Today. 12:1991;291-301.
45. Law S.K., Lichtenberg N.A., Levine R.P. Covalent binding and hemolytic activity of complement proteins. Proc. Natl. Acad. Sci. USA. 77:1980;7194-7198.
46. Law S.K., Minich T.M., Levine R.P. Covalent binding efficacy of the third and fourth complement proteins in relation to pH, nucleophilicity, and availability of hydroxyl groups. Biochemistry. 23:1984;3267-3272.
47. Sim R.B., Reid K.B.M. C1: Molecular interactions with activating systems. Immunol. Today. 12:1991;307-311.
48. Semple S.C., Chonn A., Cullis P.R. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry. 35:1996;2521-2525.
49. Mold C., Walter E.I., Medof M.E. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor. J. Immunol. 145:1990;3836-3841.
50. Young N.M., Leon M.A. The carbohydrate specificity of conglutinin and its homology to proteins in the hepatic lectin family. Biochem. Biophys. Res. Commun. 143:1987;645-651.
51. Ezekowitz R.A.B., Day L.E., Herman G.A. A human mannose-binding protein is an acute-phase reactant that shares sequence homology with other vertebrate lectins. J. Exp. Med. 167:1988;1034-1047.
52. Wright S.D., Tobias P.S., Ulevitch R.J., Ramos R.A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1989;1231-1241.
53. Tobias P.S., Soldau K., Kline L., Lee J.D., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:1993;3011-3021.
54. Savill J., Dransfield I., Hogg N., Haslett C. Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature. 343:1990;170-173.
55. Pinteric L., Assimeh S.M., Kells D.I.C., Painter R.H. The ultrastructure of C1t, a subcomponent of the first component of complement: An EM and ultracentrifuge study. J. Immunol. 117:1976;79-83.
56. Saxena U., Nagpurkar A., Dolphin P.J., Mookerjea S. A study on the selective binding of apoprotein B- and E-containing human plasma lipoproteins to immobilized rat serum phosphorilcholine-binding protein. J. Biol. Chem. 262:1987;3011-3016.
57. Kottgen E., Hell B., Kage A., Tauber R. Lectin specificity and binding characteristics of human C-reactive protein. J. Immunol. 149:1992;445-453.
58. Chonn A., Semple S.C., Cullis P.R. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of 'non-self' particles. J. Biol. Chem. 270:1995;25845-25849.
59. Igarashi M., Matsuura E., Igarashi Y., Nagae H., Ichikawa K., Triplett D.A., Koike T. Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood. 87:1996;3262-3270.
60. Price B.E., Rauch J., Shia M.A., Walsh M.T., Lieberthal W., Gilligan H.M., O'Laughlin T., Koh J.S., Levine J.S. Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. J. Immunol. 157:1996;2201-2208.
61. Brighton T.A., Hogg P.J., Dai Y.P., Murray B.H., Chong B.H., Chesterman C.N. Beta 2-glycoprotein I in thrombosis: Evidence for a role as a natural anticoagulant. Br. J. Haematol. 93:1996;185-194.
62. Schwalbe R.A., Dahlback B., Coe J.E., Nelsestuen G.L. Pentraxin family of proteins interact specifically with phosphorylcholine and/or phosphorylethanolamine. Biochemistry. 31:1992;4907-4915.
63. D.D. Roberts, R.P. Mecham (Eds.), Cell Surface and Extracellular Glycoconjugates. Structure and Function, Academic Press, San Diego, 1993.
64. Milner S.T. Polymer brushes. Science. 251:1991;905-914.
65. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. USA. 85:1988;6949-6953.
66. Lasic D.D., Martin F.J., Gabizon A., Huang S.K., Papahajopoulos D. Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta. 1070:1991;187-192.
67. Moghimi S., Illum L., Davis S., Kolb-Bachofen V. Coating particles with a block copolymer (poloxamine 908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta. 1179:1993;157-165.
68. Torchilin V.P., Papisov M.I. Why do PEG-coated liposomes circulate long? J. Liposome Res. 4:1994;725-739.
69. Bogdanov A.A. Jr., Weissleder R., Frank H.W., Bogdanova A.V., Nossiff N., Schaeffer B.K., Tsai E., Papisov M.I., Brady T.J. A new macromolecule as a contrast agent for MR angiography: Preparation, properties, and animal studies. Radiology. 187:1993;701-706.
70. Flory P.J., Krigbaum W.R. Thermodynamics of high polymer solutions. Annu. Rev. Phys. Chem. 2:1951;383-416.
71. Allen T.M., Hansen C.B., de Menzes D.E.L. Pharmacokinetics of long-circulating liposomes. Adv. Drug Deliv. Rev. 16:1995;267-284.
72. De Gennes P.G. Polymer solutions near an interface. 1. Adsorption and depletion layers. Macromolecules. 14:1981;1637-1644.
73. M.I. Papisov, L. LaPointe, S. Myagchilov, K. Poss, R. Weissleder, T.J. Brady, Underlying mechanisms of surface protection by molecular brushes: Models and reality, in: Twenty-third International Symposium on Controlled Release of Bioactive Materials, 1996, pp. 681-682.
74. M. Kurata, Y. Tsunashima, Viscosity-molecular weight relationships and unperturbed dimensions of linear chain molecules, in: J. Brandup, H.E. Himmelgut (Eds.), Polymer Handbook, Wiley, New York, chapt. VII.
75. M.I. Papisov, K. Poss, R. Weissleder, T.J. Brady, Intravenous lymphotropic polymers: The SPAR effect, in: Proceedings of the Second Meeting of the Society of Magnetic Resonance, Berkley, CA, 1994, p. 388.
76. Huang C., Mason J.T. Geometric packaging constraints in egg phosphatidylcholine vesicles. Proc. Natl. Acad. Sci. USA. 75:1978;308-310.
77. Enoch H.G., Strittmatter P. Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles. Proc. Natl. Acad. Sci. USA. 76:1979;145-149.
78. Bedu-Addo F.K., Huang L. Interaction of PEG-phospholipid conjugates with phospholipid: Implications in liposomal drug delivery. Adv. Drug Deliv. Rev. 16:1995;235-248.
79. M.I. Papisov, C. Martin, K. Poss, R. Weissleder, T.J. Brady, Amplification of steric effects in cooperative systems, in: Twenty-second International Symposium on Controlled Release of Bioactive Materials, 1995, pp. 442-443.
80. Mori A., Klibanov A.L., Torchilin V.P., Huang L. Influence of the steric barrier of amphypatic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Lett. 284:1991;263-266.
81. M.I. Papisov, K. Poss, R. Weissleder, T.J. Brady, Effect of steric protection in lymphotropic graft copolymers, in: Seventh International Symposium on Recent Advances in Drug Delivery Systems (abstracts), Salt Lake City, UT, 1995, University of Utah 1995, pp. 171-172.
82. Torchilin V.P., Omelyanenko V., Papisov M.I., Bogdanov A.A. Jr., Trubetskoy V.S., Herron D.I.N., Gentry C.A. Poly(ethyleneglycol) on the liposome surface: On the mechanism of polymer-coated liposome longevity. Biochem. Biophys. Acta. 1195:1994;11-20.
83. Lasic D.D., Woodle M.C., Martin F.J., Valentincic T. Phase behavior of Stealth-lipid-lecithin mixtures. Period. Biol. 93:1991;287-290.
84. Gref R., Domb A., Quelec P., Blunk P., Muller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 16:1995;215-234.
85. Zalipsky S. Chemistry of polyethyleneglycol conjugates with biologically active molecules. Adv. Drug Deliv. Rev. 16:1995;157-182.
86. Torchilin V.P., Trubetskoy V.S. Which polymers make nanoparticular drug carriers long-circulating? Adv. Drug Deliv. Rev. 16:1995;141-156.
87. Deluged C., Francis G.E., Fisher D. The uses and properties of PEG-linked proteins. Crit. Rev. Ther. Drug Deliv. Syst. 9:1992;249-304.
88. Rice K.G., Lee Y.C. Modification of triantennary glycopeptide into probes for the asialoglycoprotein of hepatocytes. J. Biol. Chem. 265:1990;18423-18428.
89. Haltiwanger R.S., Lehrman M.A., Eckardt A.E., Hill R.L. The distribution and localization of the fucose-binding lectin in rat tissues and the identification of a high affinity form of mannose/N-acetylglucosamine-binding lectin in rat liver. J. Biol. Chem. 261:1986;7433-7439.
90. Rohrer L., Freeman M., Kodama T., Penman M., Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343:1990;570-572.
91. Larsen C. Dextran prodrugs - structure and stability in relation to therapeutic activity. Adv. Drug Deliv. Rev. 3:1989;103-154.
92. Jeanes A. Immunochemical and related interactions with dextrans reviewed in terms of improved structural information. Mol. Immunol. 23:1986;999-1028.
93. Sim R.B., Reid K.B.M. C1: Molecular interactions with activating systems. Immunol. Today. 12:1991;307-311.
94. Haltiwanger R.S., Lehrman M.A., Eckardt A.E., Hill R.L. The distribution and localization of the fucose-binding lectin in rat tissues and the identification of a high affinity form of mannose/N-acetylglucosamine-binding lectin in rat liver. J. Biol. Chem. 261:1986;7433-7439.
95. Young N.M., Leon M.A. The carbohydrate specificity of conglutinin and its homology to proteins in the hepatic lectin family. Biochem. Biophys. Res. Commun. 143:1987;645-651.
96. Wright S.D., Tobias P.S., Ulevitch R.J., Ramos R.A. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170:1989;1231-1241.
97. Tobias P.S., Soldau K., Kline L., Lee J.D., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:1993;3011-3021.
98. Saxena U., Nagpurkar A., Dolphin P.J., Mookerjea S. A study on the selective binding of apoprotein B- and E-containing human plasma lipoproteins to immobilized rat serum phosphorilcholine-binding protein. J. Biol. Chem. 262:1987;3011-3016.
99. Papisov M., Weissleder R. Drug delivery to lymphatic tissue. Crit. Rev. Ther. Drug Carrier Syst. 13:1996;57-84.
100. M.I. Papisov, R. Weissleder, T.J. Brady, Diagnostic targeting of lymph nodes with polymeric imaging agents, in: V.P. Torchilin (Ed.), Targeted Delivery of Imaging Agents, CRC Press, Boca Raton, FL, 1995, pp. 385-402.
101. Weissleder R., Papisov M.I. Pharmaceutical iron oxides for MR imaging. Rev. Magn. Reson. 4:1992;1-20.
102. M.I. Papisov, L. Garrido, K. Poss, C. Wright, R. Weissleder, T.J. Brady, A long-circulating polymer with hydrolyzable main chain, in: Twenty-third International Symposium on Controlled Release of Bioactive Materials, 1996, pp. 107-108.
103. M. Papisov, unpublished data, 1995.
104. Gattegno L., Fabia F., Bladier D., Cornillot P. Physiological ageing of red blood cells and changes in membrane carbohydrates. Biomedicine. 30:1979;194-199.
105. Zocchi E., Guida L., Benatti U., Canepa M., Borgiani L., Zanin T., De Flora A. Hepatic or splenic targeting of carrier erythrocytes: A murine model. Biotechnol. Appl. Biochem. 9:1987;423-434.
106. Comfurius P., Senden J.M., Tilly R.H., Schroit A.J., Bevers E.M., Zwaal R.F. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim. Biophys. Acta. 1026:1990;153-160.
107. Dumaswala U.J., Greenwalt T.J. Human erythrocytes shed exocytic vesicles in vivo. Transfusion. 24:1984;490-492.
108. Muller C.P., Shinitzky M. Passive shedding of erythrocyte antigens induced by membrane rigidification. Exp. Cell Res. 136:1981;53-62.